Create a Profile
Parkinson’s Trial Enrolling Now
Help advance Parkinson’s research while exploring potential new care options. Adults diagnosed with Parkinson’s with motor symptoms may qualify for a no-cost trial.
ARISE is a global Phase 3 clinical trial. Phase 3 studies are used to gather more information about a drug’s safety and effectiveness. This study will test a new investigational drug, solengepras. This once-daily pill is designed to work in a new way. It will target a different pathway in the brain, rather than relying on dopamine replacement. This trial will test solengepras compared to a placebo. A placebo is an inactive version of the drug. The trial will see if solengepras is better at reducing “OFF”
time after 12 weeks of treatment.
See whether you may be eligible for a PD motor symptom research study today.
Create a Profile
